Illinois General Assembly - Bill Status for HB0332

Home

Legislation & Laws

Senate

House

My Legislation

Site Map

Previous General Assemblies

Bill Status of HB0332 96th General Assembly

Full Text Votes Witness Slips View All Actions Printer-Friendly Version

Short Description: PRESCRIPTION DRUG ETHICAL ACT

House Sponsors
Rep. Jack D. Franks, Fred Crespo, Deborah Mell and Eddie Washington

Last Action

Date	Chamber	Action
1/11/2011	House	Session Sine Die

Statutes Amended In Order of Appearance

New Act

30 ILCS 105/5.719 new

Synopsis As Introduced
Creates the Prescription Drug Ethical Marketing Act. Requires every manufacturer and labeler that sells prescription drugs in the State to disclose to the Director of Public Health the value, nature, and purpose of any gift, fee, payment, subsidy, or other economic benefit provided in connection with detailing or promotional or other marketing activities by the company, directly or through its pharmaceutical marketers, to any physician, hospital, nursing home, pharmacist, health benefit plan administrator, or any other person in the State authorized to prescribe or dispense prescription drugs. Requires the Director to report to the Governor and the General Assembly on the disclosures. Provides exceptions to the disclosures. Provides for injunctive relief and civil penalties for failure to disclose. Amends the State Finance Act to create the Prescription Drug Ethical Marketing Fund.

Actions

Date	Chamber	Action
1/23/2009	House	Filed with the Clerk by Rep. Jack D. Franks
1/27/2009	House	First Reading
1/27/2009	House	Referred to Rules Committee
2/4/2009	House	Assigned to Human Services Committee
2/6/2009	House	Added Co-Sponsor Rep. Fred Crespo
3/13/2009	House	Rule 19(a) / Re-referred to Rules Committee
1/27/2010	House	Assigned to Human Services Committee
2/19/2010	House	Added Co-Sponsor Rep. Deborah Mell
3/15/2010	House	Rule 19(a) / Re-referred to Rules Committee
3/26/2010	House	Added Co-Sponsor Rep. Eddie Washington
1/11/2011	House	Session Sine Die

×